PROFESSIONAL EDITION

The largest community of pharma leaders

Admin

3307 articles

AmMax Bio Announces the Appointment of Biotechnology Executive, John Varian, as Independent Board Member

REDWOOD CITY, Calif.--(BUSINESS WIRE)--AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative treatments with its proprietary dual anti-inflammatory/anti-fibrotic therapeutic platform targeting the...

Spaulding Clinical Announces Hiring of Medical Director Neal Collins, M.D.

WEST BEND, Wis.--(BUSINESS WIRE)--Spaulding Clinical Research announced today that it has hired Neal Collins, M.D., as medical director, effective February 1, 2021. In this...

PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer

ST. LOUIS--(BUSINESS WIRE)--PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In...

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced today the approval...

Stanford’s Dr. Catherine Blish Joins Deepcell’s Advisory Board

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced that Dr....

VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19

SAN FRANCISCO--(BUSINESS WIRE)--VeriSIM Life has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,908 to conduct research and...